Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide after endoscopic balloon dilation for intestinal stenosis in Crohn's disease
jRCT1051190043Completed
- Start
- Dec 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of budesonide in Crohn's disease and Bowel stenosis. Primary endpoint: Safety within 12 weeks after EBD. Started Dec 2018; status: completed.
02
Drugs
budesonide
03
Conditions
Crohn's diseaseBowel stenosis
Beyond the preview
Go deeper on jRCT1051190043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051190043.